The company that makes the technology, Proteus Digital Health, has created an ingestible sensor delivered inside small, inactive tablets that gather information and communicate it to a disposable, battery-operated patch worn on the torso.
That brings Proteus latest round of funding its seventh to 172 million.They ingested at most 34 pills per day and used the pills 90 days at most.The Proteus digital medicine platform is a medication management and adherence system that includes unique measurement tools, like sensor-enabled pills, a peel-and-stick biometric sensor patch worn on the body, and companion smartphone apps.Ingestible Sensors Market, By Value, by Sensor Type, By Value, by Sensor Application, By Value.We are very much looking forward to bringing the benefits of our ingestible sensor to the American public in the form of innovative product offerings.Phone.: 1 (214) 884-6817;.
Is developing and commercializing digital health feedback technology that is integrated into ingestible products.
These products will integrate the sensor with the active pharmaceuticals, though additional regulatory approvals are required.Depending on the pharmacys capabilities and the physicians prescription, the ingestible sensor is dispensed in 1 of 3 ways: Using stand-alone packaging, where the patient ingests 1 sensor-enabled inactive tablet each time they take their prescribed active medication.Additional physiologic and behavioral metrics collected by the patch include heart rate, body position and activity.For now, the Proteus tablet that contains the ingestible sensor is marketed as yamaha breeze workshop manual a medical minitab 16 19 digit product key device.FDA approval in July 2012 for its technology platform.Before human trials, the sensor underwent several safety tests.